These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 24048102)

  • 1. An emerging role for clarithromycin in adult-onset still disease?
    Nguyen L; Taylor-Gjevre RM
    J Clin Rheumatol; 2013 Oct; 19(7):420. PubMed ID: 24048102
    [No Abstract]   [Full Text] [Related]  

  • 2. Clarithromycin in adult-onset still's disease: a potentially useful therapeutic.
    Thanou-Stavraki A; Aberle T; Aksentijevich I; Bane BL; Harley JB
    J Clin Rheumatol; 2011 Oct; 17(7):373-6. PubMed ID: 21946464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clarithromycin in adult-onset Still's disease. Case report with a 1-year follow-up.
    Saviola G; Abdi Ali L; Shams Eddin S; Davoli C; Taglietti M
    Clin Exp Rheumatol; 2004; 22(3):379. PubMed ID: 15144141
    [No Abstract]   [Full Text] [Related]  

  • 4. Clarithromycin in adult-onset Still's disease: a study of 6 cases.
    Saviola G; Benucci M; Abdi-Ali L; Baiardi P; Manfredi M; Bucci M; Cirino G
    Rheumatol Int; 2010 Feb; 30(4):555-60. PubMed ID: 20033412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged remission in adult-onset Still's disease with etanercept.
    Kumari R; Uppal SS
    Clin Rheumatol; 2006 Feb; 25(1):106-8. PubMed ID: 15856368
    [No Abstract]   [Full Text] [Related]  

  • 6. Cyclosporin A in the treatment of adult Still's disease.
    Shojania K; Chalmers A; Rangno K
    J Rheumatol; 1995 Jul; 22(7):1391-2. PubMed ID: 7562781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adult onset Still's disease [corrected].
    Holgado S; Olivé A; Casado E; Tena X
    J Rheumatol; 2000 Jan; 27(1):279-80. PubMed ID: 10648057
    [No Abstract]   [Full Text] [Related]  

  • 8. Intravenous immunoglobulins in Still's disease: still controversial, still unproven.
    Prieur AM
    J Rheumatol; 1996 May; 23(5):797-800. PubMed ID: 8724286
    [No Abstract]   [Full Text] [Related]  

  • 9. [Tocilizumab effectiveness in adult Still's disease].
    López Buitrago R; Estrada Dorronsoro S; Cervera Segura R; Espinosa Garriga G
    Med Clin (Barc); 2012 Jan; 138(1):42-3. PubMed ID: 21605875
    [No Abstract]   [Full Text] [Related]  

  • 10. Humanized monoclonal anti-interleukin-6 receptor antibody for treatment of intractable adult-onset Still's disease.
    Iwamoto M; Nara H; Hirata D; Minota S; Nishimoto N; Yoshizaki K
    Arthritis Rheum; 2002 Dec; 46(12):3388-9. PubMed ID: 12483747
    [No Abstract]   [Full Text] [Related]  

  • 11. [Adult-onset Still's disease--the effect of methylprednisolone pulse therapy].
    Skoupý J; Alusík S
    Vnitr Lek; 1992 Dec; 38(12):1221-4. PubMed ID: 1296353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rituximab for refractory adult-onset Still's disease with thrombotic microangiopathy.
    Lee WS; Yoo WH
    Rheumatology (Oxford); 2014 Sep; 53(9):1717-8. PubMed ID: 24643525
    [No Abstract]   [Full Text] [Related]  

  • 13. Refractory adult onset Still's disease successfully treated with anakinra.
    Vasques Godinho FM; Parreira Santos MJ; Canas da Silva J
    Ann Rheum Dis; 2005 Apr; 64(4):647-8. PubMed ID: 15374853
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy of tocilizumab in refractory adult-onset Still's disease; report of 2 cases.
    Andrade-Ortega L; Irazoque-Palazuelos F; Muñoz-López S; Rosales-Don Pablo VM
    Reumatol Clin; 2014; 10(3):199-200. PubMed ID: 24076178
    [No Abstract]   [Full Text] [Related]  

  • 15. Effective treatment of steroid refractory adult-onset Still's disease with anakinra.
    Maier J; Birkenfeld G; Pfirstinger J; Schölmerich J; Fleck M; Brühl H
    J Rheumatol; 2008 May; 35(5):939-41. PubMed ID: 18464320
    [No Abstract]   [Full Text] [Related]  

  • 16. Reversal of severe hepatitis with infliximab in adult-onset Still's disease.
    Singh B; Biboa J; Musuku S; Patel C; Pugh JL; Boyer TD
    Am J Med; 2013 Feb; 126(2):e3-4. PubMed ID: 23331455
    [No Abstract]   [Full Text] [Related]  

  • 17. Autophagy inhibition in adult-onset Still's disease: still more space for hydroxychloroquine?
    Papagoras C; Chrysanthopoulou A; Mitsios A; Arampatzioglou A; Ritis K; Skendros P
    Clin Exp Rheumatol; 2017; 35 Suppl 108(6):133-134. PubMed ID: 29148405
    [No Abstract]   [Full Text] [Related]  

  • 18. Prolonged efficacy of infliximab for refractory adult-onset Still's disease.
    Dilhuydy MS; Vatan R; Etienne G; Longy-Boursier M; Mercié P
    Clin Exp Rheumatol; 2005; 23(1):121-2. PubMed ID: 15789901
    [No Abstract]   [Full Text] [Related]  

  • 19. Refractory adult onset Still's disease and hypersensitivity to non-steroidal anti-inflammatory drugs and cyclo-oxygenase-2 inhibitors: are biological agents the solution?
    Aarntzen EH; van Riel PL; Barrera P
    Ann Rheum Dis; 2005 Oct; 64(10):1523-4. PubMed ID: 16014669
    [No Abstract]   [Full Text] [Related]  

  • 20. [Adult-onset Still disease: treatment with biologic agents in refractory cases].
    Tejera B; Martínez-Morillo M; Riveros A; Olivé A
    Med Clin (Barc); 2013 Apr; 140(8):381-2. PubMed ID: 23273758
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.